Syncona Portfolio LTD Autolus Therapeutics PLC Transaction History
Syncona Portfolio LTD
- $80.7 Million
- Q3 2024
A detailed history of Syncona Portfolio LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Syncona Portfolio LTD holds 18,554,624 shares of AUTL stock, worth $41.9 Million. This represents 83.42% of its overall portfolio holdings.
Number of Shares
18,554,624
Previous 21,346,829
13.08%
Holding current value
$41.9 Million
Previous $74.3 Million
9.33%
% of portfolio
83.42%
Previous 86.45%
Shares
3 transactions
Others Institutions Holding AUTL
# of Institutions
104Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA24.2MShares$54.7 Million0.02% of portfolio
-
Blackstone Inc New York, NY20.5MShares$46.3 Million0.35% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$34.5 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$27.9 Million0.67% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E98MShares$18.1 Million10.85% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $205M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...